A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
Condition(s):Multiple MyelomaLast Updated:June 9, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:June 9, 2023Completed
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:December 8, 2023Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:January 10, 2018Completed
Condition(s):Multiple MyelomaLast Updated:August 22, 2018Terminated
Condition(s):Graft-versus-host DiseaseLast Updated:December 2, 2015Unknown status
Condition(s):Lung Transplant RejectionLast Updated:April 25, 2022Completed
Condition(s):Liposarcoma; Malignant Peripheral Nerve Sheath Tumors; Alveolar Soft Part Sarcoma; Ewing Sarcoma; SarcomaLast Updated:November 27, 2020Withdrawn
Condition(s):Multiple Myeloma; Heart Failure, Systolic; CardiotoxinsLast Updated:March 13, 2019Completed
Condition(s):Multiple MyelomaLast Updated:September 28, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:December 20, 2022Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.